Guidelines for Reporting Outcomes in Trial Reports : vimarsa

This report, the Consolidated Standards of Reporting Trials (CONSORT)–Outcomes 2022 extension, is a consensus statement on the standards for reporting outcomes

Related Keywords

United States , Canada , Toronto , Ontario , London , City Of , United Kingdom , Vermont , America , Canadian , Pharma Gmb , Robin Hayeems , James Webbe , Eli Lilly , Petros Pechlivanoglou , Lisa Stallwood , Mss Saeed , Andrea Chiaramida , Amgen , Peter Gilgan Centre For Research , American College Of Rheumatology , Cundill Centre For Child , Analysis Methods Group , Pfizer , Astrazeneca , Health Sciences , Forest Pharmaceuticals , Vertex Pharmaceuticals , Takeda Pharmaceutical Co Ltd , Drug Administration , Sickkids Foundation , School Of Public Health , Canadian Institutes Of Health Research , Key Development Phases , Laboratory Tests Along With Reliability , Parexel International , Genentech , Mental Health , Novartis , Transparency Of Health Research , Canadian Cancer Society , Research Manitoba , Td Bank Financial Group , Imperial College London , Centre For Addiction , Children Hospital Research Institute Of Manitoba , Bristol Myers Squibb , University Of Vermont , Larner College Of Medicine , Regeneron Pharmaceuticals , Reformulary Group , Savient Pharmaceuticals , Division Of Neonatal , European League , Health Research , Consolidated Standards , Reporting Trials , Cochrane Methodology Register , Reporting Planned Endpoints , Clinical Trials , Standard Protocol Items , Interventional Trials , Development Phases , Section Ref , Terms Used , Checklist Items , Outcomes Used , Primary Outcome , Specific Measurement Variable , Systolic Blood Pressure , Analysis Metric , Change From Baseline , Final Value , Time Point , Each Outcome , Minimal Important Change , Outcome Data Were Continuous , Were Analyzed , Cutoff Values Used , Outcome Assessments Were Performed , Several Time Points After Randomization , Time Points Used , Composite Outcome Was Used , Individual Components , Composite Outcome , Outcomes That Were , Trial Registry , Trial Protocol , Study Instruments Used , Laboratory Tests , Along With Reliability , Population Similar , Study Sample , Trial Specific Training Necessary , Study Instruments , Wechsler Abbreviated Scale , Processes Used , Duplicate Measurements , After Data Collection , Range Checks , Outcome Data Values , Checklist Item , Sample Size , Target Difference Between Treatment Groups , Minimal Important Difference , Difference Elicitation , Statistical Methods , Methods Used , Secondary Outcomes , Coprimary Outcomes , Same Outcome Assessed , Multiple Time Points , Subgroup Analyses , Outcome Data From , Report That , Outcome Data Were Excluded , Assess Patterns , Handle Missing Outcome Items , Entire Assessments , Outcome Analysis Population Relating , Randomized Analysis , Prespecified Outcome Analyses , Estate Where , Results Can Be Found , Ancillary Analyses , There Were , Analyses That Were , They Were Performed , North America , Peter Gilgan Centre , Sick Children , Interest Disclosures , Cundill Centre , Youth Depression , Canadian Institutes , Hospital Research Institute , Cochrane Prospective Meta Analysis Methods , Hoffmann La Roche , Horizon Therapeutics , American College , Treating Anxiety Disorders , Young Children , Financial Group , Drs Butcher , Executive Deputy Editor , Cochrane Neonatal , Neonatal Perinatal Medicine , Larner College , Chris Gale , Neonatal Medicine , Public Health , Open Science Framework ,